Sold Syngene
I sold the Syngene after the Q4FY24 quarterly results. I know the business of custom synthesis should not be judged QoQ but I was already planning to exit the Syngene because I think I can not understand enough in deep to predict its sales or profits. Not so good quarterly results causes the stock to go down and as I wanted to exit the stock, I thought it was a good time to exit.
Others reasons as mentioned here
I sold near to 700, my average buy price was at 550. I mostly added near to 50 percent each in 2023 and 2022.
Sold Indigo
I also sold the Indigo as could not got hold of their business with few percentage point profit.
Reason was my theory of margin not sustaining but it seems that at even the current elevated flight prices, the Air India is operating is loss, so maybe the margin expansion is here to stay.
Also top mutual funds have added Indigo in March and April.
Neuland concall question
I asked a question in recent Neuland concall.
I could not get the answer that I was looking. I later realised, maybe because my question seemed forward looking.
The better way to ask this question would have been,
Will it be fair to assume that our commercialised API and intermediates count will not decrease QoQ?
or
I could have simply asked, how to understand the decrease in commercialised intermediates count in recent quarters.
Something different that I tried
I tried one strategy for trading and I was able to predict a lot things but could not predict the people response and has to book near to 5% loss over 3.5% of my net worth.
It was difficult to book loss when the loss comes in just few days but we should maintain discipline.
Also the loss is permanent which makes it little difficult.
Subscribe To Our Free Newsletter |